
NPHCDA opens special COVID-19 vaccination sites, says Executive Director
Health
THE National Primary Health Care Development Agency (NPHCDA) says some special COVID-19 vaccination sites have been set up across the country.
The Executive Director, NPHCDA, Dr. Faisal Shuaib made this known while addressing newsmen in Abuja,
Shuaib said that the sites were set up to ensure that every Nigerian who had received the first jab completes the process.
“We acknowledge the possibility of some people relocating from the states where they took their first doses.
“For this reason, we have made provision for special vaccination sites that could accommodate administering their second doses,” he said.
He allayed the fears of Nigerians due to the side effects of the vaccines.
”There have been cases of mild, moderate, and severe adverse effects since the vaccination campaign was officially rolled out.
“These side effects include pain and swelling at the site of vaccination to more serious symptoms such as headaches, abdominal pain, fever, dizziness, and allergic reactions.
“A total of 10,027 cases of mild Adverse Event Following Immunization (AEFI) have been reported as of May 30″, while 86 cases of moderate to severe incidents have been reported. All these individuals have since fully recovered,” Shuaib said.
According to him, five states have the highest records of AEFI namely: Cross River (1,040), Kaduna (1,071), Lagos (796), Yobe (555), and Kebbi with 525 cases.
Shuaib added ” indeed on my part, the side effects following the second dose was much less than the first dose.
“We continue to advise that all Nigerians who have received their first dose should check their vaccination cards for the date of their second dose.
”They are to proceed to the same health facility where they got their first jab, to ensure full protection against COVID-19.
Also speaking, the United Nation’s Children Fund (UNICEF) in Nigeria, representative, Dr Gupta Gagan, commended the NPHCDA and its leadership for the ongoing COVID-19 vaccination drive.
Gupta said the challenges faced in the administration of the vaccine would be reaching out to citizens to go and receive their second doses.
“All those who have received the first dose should please go back for their second dose because if you don’t you should know that you are not fully protected.
The World Health Organisation (WHO) Representative to Nigeria, Dr. Walter Kazadi Mulombo, also commended Nigeria’s COVID-19 vaccination strategy.
He disclosed that other African countries are already looking up to Nigeria to learn how to roll out their vaccinations.
“Even though Africa is lagging behind, Nigeria is among the countries that is distributing the most COVID-19 vaccines.
“We know that in terms of volume we are still a long way to go because we have planned to vaccinate more than 100 million of our population.
”However, its already a good learning base on how we can effectively rollout the COVID-19 vaccination,” he added. (NAN)
– June 02, 2021 @ 09:57 GMT
Related Posts

NDLEA Recognizes NDI as Anti-Drug NGO Partner
THE National Drug Law Enforcement Agency, NDLEA, has officially registered the Nery Developmental Initiative, NDI, as a collaborating Non-Governmental Organization,...
Read More
We’ll regulate hospitality sector to boost IGR, Oyo Govt says
IN line with the commitment of Governor ‘Seyi Makinde to expand the economy of Oyo State through tourism and hospitality,...
Read More
WHO says breast cancer cases projected to rise by 38% by 2050
WORLD Health Organisation (WHO) says in a new report that breast cancer cases are expected to increase by 38 per...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.